Orally administered plastid expressed cholera toxin B subunit-exendin 4 as treatment for type 2 diabetes
US10655135B2 · kind B2 · utility
0Cited by
13References
17Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 24, 2012 |
| Grant date | May 19, 2020 |
| Priority date | — |
| Expiry date | Oct 24, 2032 |
Classification
- Technology area (CPC —)General
Abstract
Disclosed herein are compositions and methods for treating Type II diabetes. The compositions comprise plant expressed Exendin 4. Particularly exemplified are plant derived compositions that include a CTB-EX4 conjugate that is bioencapsulated in chloroplasts.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.